Robert Ryan, Ph.D., has been appointed vice president, Regulatory Strategy, Consulting and Submissions at INC Research. Dr. Ryan will provide global leadership to the Advisory Services Unit and help customers navigate the complexities of the regulatory environment and accelerate time to market. 
 
Dr. Ryan is an experienced senior regulatory affairs executive with more than 20 years of experience in the biopharmaceutical industry. He has held regulatory and executive leadership positions in both the CRO and biopharmaceutical industries with companies such as Quintiles, PPD, Celtic Therapeutics and Schwarz Pharma. Most recently, he was chairman of the board for Levare, LLC, a  pharma development company. 
 
“Robert brings a unique blend of strategic leadership skills and international regulatory expertise that speaks to biopharmaceutical companies looking for guidance along the entire continuum of the drug development lifecycle,” said Tim Dietlin, senior vice president, Global Consulting and Strategic Alliances. “Our Regulatory Consulting and Submissions team has a long history of exceptional work, and we look forward to continuing this track record under Robert's leadership.”